Molecules,
Год журнала:
2024,
Номер
29(23), С. 5764 - 5764
Опубликована: Дек. 6, 2024
In
this
study,
homoisoflavone
methylophiopogonanone
A
(MOA)
was
investigated
for
its
inhibitory
effect
on
ferroptosis
of
H9c2
cells
using
a
set
cellular
assays,
such
as
BODIPY-probed
and
H
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Янв. 21, 2025
Background
Doxorubicin
(DOX),
a
widely
employed
chemotherapeutic
agent
in
cancer
treatment,
has
seen
restricted
use
recent
years
owing
to
its
associated
cardiotoxicity.
Current
reports
indicate
that
doxorubicin-induced
cardiotoxicity
(DIC)
is
complex
phenomenon
involving
various
modes
of
cell
death.
Astaxanthin
(ASX),
natural
carotenoid
pigment,
garnered
significant
attention
for
numerous
health
benefits.
Recent
studies
have
shown
ASX
broad
and
effective
cardiovascular
protective
effect.
Our
study
aims
investigate
the
effects
against
DIC
elucidate
underlying
mechanisms.
This
substantial
practical
significance
clinical
application
DOX.
Methods
Bioinformatic
analyses
were
conducted
using
transcriptomic
data
from
gene
expression
omnibus
(GEO)
database
identify
key
mechanisms
DIC.
Network
pharmacology
was
predict
potential
pathways
targets
through
which
exerts
on
In
vitro
experiments,
following
pretreatment
with
ASX,
H9C2
cells
exposed
Cell
viability,
injury
protein
levels
ferroptosis
autophagy
assessed.
animal
rats
underwent
4
weeks
gavage
treatment
doses
followed
by
intraperitoneal
injections
DOX
every
2
days
during
final
week.
Histological,
serum,
evaluate
Results
The
bioinformatics
analysis
revealed
are
closely
development
may
exert
an
anti-DIC
effect
modulating
autophagy.
experimental
results
show
significantly
mitigates
DOX-induced
myocardial
tissue
damage,
inflammatory
response,
oxidative
stress,
damage
cells.
Mechanistically,
markedly
ameliorates
both
vivo
.
Specifically,
upregulates
solute
carrier
family
7
member
11
(SLC7A11)
glutathione
peroxidase
(GPX4),
while
downregulating
transferrin
receptor
1
(TFRC),
ferritin
heavy
chain
(FTH1)
light
(FTL).
Additionally,
enhances
P62
decreases
Beclin1
microtubule-associated
proteins
3
(LC3).
Conclusion
critical
factors
influencing
occurrence
progression
can
alleviate
inhibiting
Frontiers in Cellular Neuroscience,
Год журнала:
2024,
Номер
18
Опубликована: Окт. 15, 2024
Ferroptosis
represents
an
iron
−
and
lipid
peroxidation
(LPO)-mediated
form
of
regulated
cell
death
(RCD).
Recent
evidence
strongly
suggests
the
involvement
ferroptosis
in
various
neurodegenerative
diseases
(NDs),
particularly
Alzheimer’s
disease
(AD),
Parkinson’s
(PD),
Huntington’s
(HD),
multiple
sclerosis
(MS),
amyotrophic
lateral
(ALS),
among
others.
The
treatment
poses
both
opportunities
challenges
context
ND.
This
review
provides
a
comprehensive
overview
characteristic
features,
induction
inhibition
ferroptosis,
highlighting
inhibitor
underlying
mechanisms
responsible
for
its
occurrence.
Moreover,
explores
how
these
contribute
to
pathogenesis
progression
major
disorders.
Additionally,
it
presents
novel
insights
into
role
ND
summarizes
recent
advancements
development
therapeutic
approaches
targeting
ferroptosis.
These
hold
potential
guide
future
strategies
aimed
at
effectively
managing
debilitating
medical
conditions.
International Journal of Nanomedicine,
Год журнала:
2025,
Номер
Volume 20, С. 1637 - 1659
Опубликована: Фев. 1, 2025
Abstract:
Kidney
diseases
are
a
significant
global
cause
of
death
and
disability,
resulting
from
the
destruction
kidney
structure
function
due
to
an
imbalance
between
renal
parenchymal
cells
proliferation
or
recruitment
maladaptive
cells,
caused
by
various
pathogenic
factors.
Currently,
therapies
their
efficacy
for
limited.
Ferroptosis
is
newly
discovered
iron-dependent
regulated
cell
death.
The
iron
homeostasis
lipid
metabolism
affects
occurrence
progression
triggering
ferroptosis,
which
considered
important
target
development
disease
drugs.
However,
in
clinical
practice,
targeted
ferroptosis
therapy
faces
obstacles
such
as
poor
drug
solubility,
low
resistance,
imprecise
targeting.
With
rapid
nanomaterials
medical
field,
new
opportunities
have
emerged
precise
regulation
treatment
diseases.
This
article
provides
detailed
introduction
regulatory
mechanisms
properties
nanomaterials,
application
diseases,
with
focus
on
discussing
action
therapeutic
potential
based
aim
this
provide
ideas
directions
future
treatments.
Keywords:
nanomaterial,
nanomedicine,
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 26, 2025
Drug
resistance
is
a
prevalent
challenge
in
clinical
disease
treatment,
often
leading
to
relapse
and
poor
prognosis.
Therefore,
it
crucial
gain
deeper
understanding
of
the
molecular
mechanisms
underlying
drug
develop
targeted
strategies
for
its
effective
prevention
management.
Mitochondria,
as
vital
energy-producing
organelles
within
cells,
have
been
recognized
key
regulators
sensitivity.
Processes
such
mitochondrial
fission,
fusion,
mitophagy,
changes
membrane
potential,
reactive
oxygen
species
(ROS)
accumulation,
oxidative
phosphorylation
(OXPHOS)
are
all
linked
Non-coding
RNAs
(ncRNAs)
enriched
mitochondria
(mtncRNA),
whether
transcribed
from
DNA
(mtDNA)
or
nucleus
transported
mitochondria,
can
regulate
transcription
translation
mtDNA,
thus
influencing
function,
including
substance
exchange
energy
metabolism.
This,
turn,
directly
indirectly
affects
cellular
sensitivity
drugs.
This
review
summarizes
types
mtncRNAs
associated
with
regulating
resistance.
Our
aim
provide
insights
overcoming
by
modulating
mtncRNAs.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 16, 2025
AbstractBackground
The
severe
cardiotoxicity
of
doxorubicin
(Dox)
significantly
restricts
its
clinical
application.
Deubiquitinating
enzymes
(DUBs)
play
pivotal
roles
in
cardiac
pathophysiology
because
their
precise
regulation
protein
function,
localization
and
degradation.Objectives
objective
this
study
was
to
investigate
the
role
molecular
mechanism
ubiquitin-specific
peptidase
20
(USP20),
a
DUB,
doxorubicin-induced
cardiotoxicity.Methods
Cardiomyocyte-specific
USP20-knockout
(USP20-CKO)
mice
were
utilized
assess
USP20
cardiomyopathy
(DIC).
Coimmunoprecipitation
(co-IP)
combined
with
liquid
chromatography‒mass
spectrometry/mass
spectrometry
(LC‒MS/MS)
analysis
employed
screen
substrate
USP20.
Furthermore,
mutant
plasmids
constructed
elucidate
underlying
human
antigen
R
(HuR)
by
Finally,
an
AAV9
vector
used
overexpress
hearts
cardiac-specific
HuR-knockout
interaction
between
HuR.Results
results
revealed
decrease
expression
Dox-stimulated
mouse
cardiomyocytes.
knockout
resulted
increased
cardiomyocyte
ferroptosis
led
DIC.
Mechanistically,
directly
interacted
HuR
through
protease
structural
domain.
Deubiquitination
at
position
154
crucial
for
maintaining
stability
cleaving
K48
ubiquitin
chains
inhibiting
proteasomal
degradation.
Additionally,
bound
GPX4
mRNA
suppress
degradation,
thereby
mitigating
contributing
alleviating
targeted
overexpression
via
cardiomyocytes
alleviated
However,
cardiomyocyte-specific
knockout,
no
longer
had
anti-DIC
effect,
indicating
that
HuR,
as
downstream
target
USP20,
plays
irreplaceable
DIC.Conclusions
Our
findings
indicate
enhances
deubiquitination,